Lab diagnosis of MI
Reading File
Finding Sources
Finding Sources
Searching PubMed
"myocardial infarction" AND "biomarkers" AND "diagnosis"
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Reading File
Reading File
Finding Sources
Reading File
I now have everything needed for a comprehensive answer. Let me compile the full response:
Laboratory Diagnosis of Myocardial Infarction (MI)
Principle
When myocardial cells are damaged, intracellular proteins leak through disrupted cell membranes into the bloodstream. The AMI (4th Universal Definition) requires a rise and/or fall in cardiac biomarker values with at least one value above the 99th percentile upper reference limit (URL), in the setting of symptoms, ECG changes, or imaging evidence of ischemia.
- Harrison's Principles of Internal Medicine 22E, p. 2159
Primary Biomarkers
1. Cardiac Troponins (cTnI and cTnT) - GOLD STANDARD
Troponin I and Troponin T are components of the cardiac contractile apparatus. Their amino acid sequences differ from skeletal muscle isoforms, allowing highly specific monoclonal antibody-based assays.
| Feature | Details |
|---|---|
| Onset of rise | 2-4 hours after MI (detectable within 1 hour with hs-assays) |
| Peak | ~24-48 hours (may peak earlier with reperfusion) |
| Duration of elevation | 7-10 days (up to 14 days in large infarcts) |
| Cut-off | 99th percentile of a reference population (URL) |
High-sensitivity (hs) troponin assays have detection thresholds of ~1-2 ng/L and a 99th percentile URL of ~10-30 ng/L. They enable:
- Rapid rule-out in 1-2 hours (serial testing)
- Negative predictive value >99% at presentation if patient is >2-3 hours from symptom onset
- Serial measurement at 0 h and 1-3 h (hs-assay) or 0 h and 3-6 h (conventional assay)
cTnI vs cTnT:
-
cTnI is entirely cardiac-specific; never expressed outside the heart under normal conditions
-
cTnT can be elevated in neuromuscular diseases (rare cases) without cardiac involvement - in such cases, cTnI is preferred
-
In renal failure, cTnT may be disproportionately elevated; cTnI is preferred
-
Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 313; Goldman-Cecil Medicine, p. 657
Causes of troponin elevation other than MI (important for interpretation):
- Myocarditis, pericarditis
- Heart failure, pulmonary embolism
- Stroke, intracranial hemorrhage
- Septic shock, renal failure
- Cardiac contusion, cardioversion
2. Creatine Kinase-MB (CK-MB)
CK-MB is an isoenzyme of creatine kinase predominantly found in myocardium. It is no longer the recommended initial diagnostic marker but has specific utility.
| Feature | Details |
|---|---|
| Onset | 2-4 hours after MI |
| Peak | 24-48 hours |
| Return to normal | ~72 hours (3 days) |
| Relative index | CK-MB mass/CK activity ≥2.5 suggests myocardial source |
Remaining clinical role of CK-MB:
-
Diagnosis of early reinfarction - because CK-MB returns to normal faster than troponin (~72h vs 7-10 days), it is useful when re-MI is suspected in a patient already with an elevated troponin from the index event
-
CK-MB lacks specificity because it is present in both skeletal and cardiac muscle
-
Harrison's Principles of Internal Medicine 22E, p. 2159; Washington Manual of Medical Therapeutics
3. Myoglobin
| Feature | Details |
|---|---|
| Onset | Earliest marker - rises within 1-2 hours |
| Peak | 4-8 hours |
| Return to normal | 24 hours |
| Specificity | Low - present in skeletal muscle as well |
Myoglobin was historically useful for its early negativity (a normal myoglobin at 4-8 hours after symptom onset has good negative predictive value), but its poor specificity has limited its use. It has been largely superseded by hs-troponin assays.
4. Lactate Dehydrogenase (LDH)
| Feature | Details |
|---|---|
| Onset | 24-48 hours |
| Peak | 3-6 days |
| Duration | Up to 8-14 days |
| Isoenzyme | LDH1 > LDH2 ("flipped ratio") is cardiac-specific |
LDH1/LDH2 ratio >1 ("LDH flip") indicates myocardial damage. LDH is a late marker - historically useful for diagnosing MI when the patient presents late (>48-72h after symptom onset, after CK-MB has normalized). Now largely replaced by troponin's prolonged elevation.
Biomarker Kinetics Graph
This graph illustrates the temporal rise and fall of key biomarkers after MI:
Fig. 9.13 from Robbins & Kumar Basic Pathology - Note how Troponin I rises highest and persists longest (7-10 days), CK-MB peaks at 24h and returns to normal by ~72h, and Myoglobin rises earliest but falls back quickly within 24h.
Summary Table: Biomarker Comparison
| Marker | Onset | Peak | Returns to Normal | Specificity | Current Role |
|---|---|---|---|---|---|
| cTnI / cTnT | 2-4 h (hs: <1h) | 24-48 h | 7-14 days | Very high | Primary marker - Gold standard |
| CK-MB | 2-4 h | 24-48 h | ~72 h | Moderate | Reinfarction detection |
| Myoglobin | 1-2 h | 4-8 h | 24 h | Low | Early rule-out (superseded) |
| LDH (LDH1>LDH2) | 24-48 h | 3-6 days | 8-14 days | Low-moderate | Late presentation (historical) |
Other Routine Laboratory Tests in MI
Along with cardiac biomarkers, the following are obtained in all patients:
- CBC - WBC leukocytosis (12,000-15,000/μL) peaks 2-4 days after MI (polymorphonuclear); provides baseline before antiplatelet/anticoagulant therapy
- Metabolic panel (BMP/CMP) - Electrolytes, glucose, renal function
- Fasting lipid panel - Baseline for statin therapy (note: lipids may fall in first 24-48h after MI)
- Coagulation tests (PT, aPTT) - Baseline before thrombolytic/anticoagulant therapy
- BNP/NT-proBNP - Elevated with ventricular wall stress; provides prognostic information; severe elevation suggests large infarction
- Blood glucose - Hyperglycemia is common; a marker of stress and poor prognosis
- Goldman-Cecil Medicine, pp. 657-658; Washington Manual of Medical Therapeutics, p. 133
Diagnostic Criteria (4th Universal Definition of MI)
The diagnosis of AMI requires acute myocardial injury (rising and/or falling troponin with ≥1 value above 99th percentile URL) plus at least one of:
- Symptoms of myocardial ischemia
- New ischemic ECG changes
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or wall motion abnormality in a pattern consistent with ischemic etiology
- Intracoronary thrombus identified on angiography or autopsy
The distinction between MI and other causes of myocardial injury (myocarditis, stress cardiomyopathy) requires clinical context - troponin elevation alone is not sufficient; a temporal rise-and-fall pattern must be demonstrated.
- Harrison's Principles of Internal Medicine 22E, p. 151
This is a shared conversation. Sign in to Orris to start your own chat.